Jayne Gershkowitz

Jayne Gershkowitz is a declared insider of Amicus Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 10 April 2014 and 1 July 2015, the trades on record add up to 14 filings.

The open-market side counts 3 purchases for €74k alongside 6 sales for €421k. Sales outweigh purchases by €347k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants and 3 option exercises. Since January 2015: no purchases and 3 sales on the market.

The median purchase comes to €25k.

The record was last updated on 1 July 2015 with an open-market sale (€135k) in Amicus Therapeutics, Inc. The clock since the last published purchase (29 August 2014) now reads 4,455 days. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.